This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Gilead Sciences Inc (GILD)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 10.03B 2.11B 1.80B 9.88B
Receivables 4.64B 2.10B 1.75B 1.95B
Inventories 1.39B 2.06B 1.74B 1.39B
Other Current Assets 472.00M 91.92M 348.42M 126.85M
Total Current Assets 17.71B 7.27B 6.16B 13.92B
Property, Plant & Equipment, Gross 2.29B 1.67B 1.52B 1.13B
Accumulated Depreciation & Depletion 620.00M 501.97M 423.30M 358.26M
Property, Plant & Equipment, Net 1.67B 1.17B 1.10B 774.41M
Intangibles 11.07B 11.90B 11.74B 1.06B
Other Non-Current Assets 2.80B 832.96M 1.05B 398.96M
Total Non-Current Assets 16.95B 15.22B 15.08B 3.38B
Liabilities & Shareholder Equity
Total Assets 34.66B 22.50B 21.24B 17.30B
Accounts Payable 955.00M 1.26B 1.33B 1.21B
Short Term Debt 483.00M 2.70B 1.17B 1.57M
Other Current Liabilities 105.00M 10.86M 13.40M 40.58M
Total Current Liabilities 5.76B 6.33B 4.27B 2.51B
Long Term Debt 11.92B 3.94B 7.05B 7.61B
Deferred Income Taxes 51.00M 83.29M 0.00 0.00
Other Non-Current Liabilities 1.11B 404.87M 364.39M 315.26M
Minority Interest -42.00M -17.52M -17.97M -14.58M
Total Non-Current Liabilities 13.48B 4.80B 7.66B 8.05B
Total Liabilities 19.24B 11.13B 11.93B 10.56B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 15.43B 11.37B 9.31B 6.74B
Common Par 2.00M 1.53M 760.00K 753.00K
Additional Paid In Capital 2.39B 5.39B 5.65B 4.90B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 12.73B 6.11B 3.70B 1.78B
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 301.00M -124.45M -45.62M 58.20M
Total Capitalization 27.35B 15.31B 16.36B 14.34B
Total Equity 15.43B 11.37B 9.31B 6.74B
Total Liabilities & Stock Equity 34.66B 22.50B 21.24B 17.30B
Total Common Shares Outstanding 1.50B 1.53B 1.52B 1.51B
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 1.52B 1.53B 1.51B 1.55B
Diluted Weighted Shares Outstanding 1.65B 1.69B 1.58B 1.58B
Number of Employees 7000 6100 5000 4500
Number of Part-Time Employees 0 0 0 0

GILD Gilead Sciences Inc

Chart of GILD

Analysts Ratings for GILD

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 11 10 11 10
Moderate Buy 3 2 3 3
Hold 1 1 1 2
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0

Brokerage Partners

GILD Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs